Conference & Exhibition News

Senior leaders from across the Pharmaceutical supply chain met at CPHI Worldwide 2019 to discuss how we build a future-fit workplace that ensures everybody has the opportunity to fulfil their full potential. 

Webinar will help manufacturers to harness the advantages of using real-time analytics to enhance performance and reduce waste.

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Syntegon's new coater series can handle tablets with highly potent active ingredients.

The pharmaceutical events world doesn't have to stop for coronavirus. Join us for expert insight and analysis on how pharma is responding to the COVID-19 pandemic in several key areas.

Submit your entry before 1 July 2020!

Date alteration taken at the request of exhibitors to ensure the international character of China’s largest pharma exhibition.

Trade shows and exhibitions are key platforms for buyers and sellers of pharmaceutical ingredients, products and solutions to meet, network and do business. With the exhibitions industry having to adapt quickly to the fallout of COVID-19, what's th...

Syntegon to showcase flexible solutions for small and microbatches, new developments for liquid filling and assembly, as well as AI-enhanced product safety.

Pharmapack Europe offers a content programme which covers the latest packaging developments, opportunities and regulatory changes affecting both major and developing markets. 

The Women in Leadership Forum is a networking and knowledge-sharing event for pharma executives to share experiences and strategies for bringing diversity and equal opportunities to the industry.

Recognizing the importance of empathetic leadership to business growth and sustainability

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

The future of value-added medicines will see gamification transforming the engagement of therapies.

Event move ensures extra precautions and safety measures taken

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

CPHI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPHI, including CPHI North America—the only event to bring the entire North American pharmac...

Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.

Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.

The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years.

Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment.

But personalized medicines will require new logistics and manufacturing systems.

Demand for biological manufacturing is growing faster than capacity growth.

A shortage of qualified personnel may be a drag factor in cell and gene therapies; in China 100,00L of capacity will need to be added every year to meet bio demand.

Germany establishes itself as Europe's leading pharma market in 2019.

Outsourcing, biologics, generics and patient compliance look set to get tongues wagging at this year's CPHI WW.

CPHI Worldwide's Annual Report suggests repeat offenders of regulatory infringements should be barred from importing into the US.

Experts to discuss innovative solutions to rare disease clinical trials.

The winners’ shortlist is packed with 40 of the industry’s most innovative companies and individuals who are shaping the future of pharma.

Doyen Technologies is a Pharma Project Consultant and Project Management Company. Catering to API / Bulk Drugs and Formulation Projects across the Globe

In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.

Report predicts tomorrow’s biggest industry winners will need to invest now ahead of the curve.

Event sees new Memorandum of Understanding signed by PROLMED and KPTA.

Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth.

Use your voice to shape CPHI Worldwide's third annual global survey of the major trends, changes and developments in the industry.

Pipeline of new drugs has helped drive increased innovation in packaging and drug delivery devices.

Opportunities abound at CPHI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region.

Korean companies are opening more facilities overseas and using CPHI Korea to look for new international partners.

Great Hall of China: Informa adds additional capacity to Asia’s largest pharma event with record 66,000+ visits from 141 countries.

Demonstrates the unique ability of diffusional sizing to assess protein binding in-solution and for difficult-to-study systems.

Becomes one of only a few companies in the contract development and manufacturing market that can produce HPAPIs at such low OELs.

PASCOE Naturmedizin is one of Germany's 100 most innovative medium-sized enterprises. The success story of our family’s specialist naturopathy company began three generations and almost 125 years ago when Friedrich H. Pascoe's first pharmacy in Mülh...

Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration.

Inspiration, innovation and technical highlights from Bosch Packaging Technolgy's Pharmatag 2019.

Regulatory reforms and harmonisation reported as key drivers of industry in China.

UAE consumers and insurance companies are willing to pay for highest quality drug products.

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Number of visitors seeking a contract manufacturer was extremely high, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.

Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil.

India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production.

New guidelines will see poorer quality manufacturers drop out of the market.

The ingredients are extracted from the first organically certified rambutan gardens in Vietnam.

Generics consumption increasing, and the removal of long-list products is opening up funding towards true innovation.

Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019.

Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

Line of Sight approach to freeze-drying enables organizations to bring pharmaceutical products safely and quickly to market.

Executives predict Japan to be the second fastest growing mature market for solid dose drugs in 2019, and the second fastest overall country for biologicals growth.

2019 will mark Uniplast's debut at this year's edition of CPHI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging.

Healthcare and pharmaceutical reforms, designed to increase access to high-value medicines, driving growth.

Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.

New report highlights Germany, France and Switzerland as tier-one nations for ‘drug delivery innovation’, and warns the challenge will be to scale-up and approve promising prototypes.

The exhibition district will see the world's largest pharma industry event.

New active ingredients coming from the research of BASF’s innovation platforms on epigenetics, microbiome and extraction.

Main drivers cited as ‘high-growth domestic market’ and ‘expanding manufacturing exports’.

Event sees more innovation centralising at the Paris hub with entries for the awards and Start-up Hub opening.

BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry.

Eight of the top ten pharma nations reporting improving market conditions.

17 winners chosen from over 250 entries, with Nanobiotix winning both ‘CEO‘ and ‘Pharma Company of the Year’ categories.

Therapeutic ADC market expected to reach $4 billion by 2023.

Companies new to CPHI to showcase an exciting range of products and services ranging from electroceuticals to refrigerant alternatives.

Smaller bioreactors and high-density perfusion techniques needed as manufacturing makes significant efficiency improvements.

GARDair removes the need for animal testing and opens a completely new market.

China is harmonizing to ICH standards at feverish pace and will force poor quality manufacturers out of market.

US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest.

CPHI Annual Report expert sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move past regulatory diktats.

CPHI Middle East & Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government reforms to further increase local manufacturing.

FDF launches at CPHI Korea as country set to become regional hub.

Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.

Company's Wear Indicator Layer attracts the most attention.

Experts warn bio industry needs to do more to create a sustainable pipeline of talent.

The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences.

The Wear Indicator Layer is expected to have a "huge impact" on customers' production.

Forgotten markets of Africa and Arabia to see increased growth fuelled by international and domestic partnerships and imported APIs.

Testa Anayltical to discuss their latest developments and application advances in Light Scattering technology, GPC/SEC instrumentation and Zeta potential measurement.

Bosch's new Xelum R&D for continuous production of oral solid dosage forms ensures a short time-to-market and optimum dosing of APIs.

2018 event prepares for surge in international attendees as MAH nears national rollout.

Managing the risks associated with Industrial Hygiene and Quality and meeting operational efficiency targets.

New Industry 4.0 solutions from Bosch for more transparency.

Energy efficient, short cycle times and reliable product quality in large batches.

Company to bring its new services and products into the spotlight at ACHEMA.

Sartorius Stedim Biotech introduces its mini microcarrier bioreactor for culturing adherent cells.

SVP250 LF processing system minimizes product loss thanks to conical vessel shape.

The event will annually switch between Indonesia and Thailand to cater to attendees that were previously unable to participate.

The IHD series has been specially designed for coating and granulating pharmaceutical products with hot greases and waxes.

Pharma Liquid World shows the connection of a preparation system and filling machine, as well as robotic technology in aseptic filling.

Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness.

Bio and generic demand reflective of wider trends in the market – with overseas investments now prospering.

Experts forecast the personalised medicines, intelligent packaging and regulatory deadlines as the industry's biggest development.

ASEAN Economic Community and relaxed rules on foreign ownership driving increases in international investment and partnerships.

Packaging innovation shows a clear focus on patient compliance and ease-of-use.

PAA showcases its complete range of automation solutions, suitable for any type of laboratory or application, at SLAS2018.

A new analytical tool, Electrical Asymmetrical Flow Field-Flow Fractionation (EAF4) is showing much promise in biopharmaceutical and nanoparticle applications.

Love it or loathe it, plastic is here to stay, but that doesn't let the pharmaceutical industry off the hook.

New Year CPHI Japan report predicts 2018 will be a transformative year for Japanese pharma, with early movers likely to benefit.

Three anti-ageing and anti-stress active ingredients for manufacturers of skin care product

New 3D technology provides a powerful platform for skin care researchers wishing to study the function of sebaceous glands, in relation to a range of age-related, microbial and inflammatory skin disorders.

Integration of supply chain a critical issue as industry globalises, with a resurgence in European manufacturing and biotech markets forecast.

A highly automated system to speed up testing, improve reproducibility, and enhance data output and recording.

Germany tops quality-ranking categories in the inaugural CPHI Global Pharma Index.

Perception of India’s API manufacturing seems to be improving.

New event to create unique synergies between the parallel worlds of large, small molecules and contract services.

19 winners chosen from 200 entries, received from nearly 30 countries worldwide.

Experts state pharmaceutical regulation will shift due to increased data dependence, warn regulatory oversight is slowing six sigma adoption, and forecast increased generic options 2025 onwards.

Country accounts for over 20% of global production with $20 billion exports forecast by 2020.

Comprehensive 2-day event takes attendees through the most common problems found in modern tablet production, from sticking and picking to weight control and capping.

Experts predict PAT/QbD and CM adoption may take 10 years, with smaller generic players to drop out of the market if unable to innovate in time.